Sign In to View Organizational & Contract Pricing
Select a Size
About This Item
Empirical Formula (Hill Notation):
C31H60O5
CAS Number:
Molecular Weight:
512.81
Beilstein:
1808871
MDL number:
UNSPSC Code:
12352211
PubChem Substance ID:
NACRES:
NA.25
biological source
synthetic (organic)
Quality Level
Assay
≥95%
form
powder
functional group
ketone
lipid type
neutral glycerides
storage temp.
2-8°C
SMILES string
CCCCCCCCCCCCCC(OC[C@H](CO)OC(CCCCCCCCCCCCC)=O)=O
InChI
1S/C31H60O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-30(33)35-28-29(27-32)36-31(34)26-24-22-20-18-16-14-12-10-8-6-4-2/h29,32H,3-28H2,1-2H3/t29-/m0/s1
InChI key
JFBCSFJKETUREV-LJAQVGFWSA-N
Looking for similar products? Visit Product Comparison Guide
Related Categories
Application
1,2-Dimyristoyl-sn-glycerol (1,2-ditetradecanoyl-sn-glycerol) may be used as a reactant in the preparation of 1,2-[13,13-2H2]dimyristoyl-sn-glycero-3-phosphoethanolamine and sodium 1,2-ditetradecanoyl-sn-glycer-3-yl phenyl phosphate.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Orientation of the headgroup of phosphatidylinositol in a model biomembrane as determined by neutron diffraction.
Bradshaw JP, et al.
Biochemistry, 38(26), 8393-8401 (1999)
L D'Abundo et al.
Oncogene, 36(47), 6617-6626 (2017-08-08)
Dysregulation of microRNAs (miRNAs) plays an important role in the pathogenesis of chronic lymphocytic leukemia (CLL). The Eμ-TCL1 transgenic mouse develops a form of leukemia that is similar to the aggressive type of human B-CLL, and this valuable model has
Dynamic structure and phase behavior of dimyristoylphosphatidylethanolamine bilayers studied by deuterium nuclear magnetic resonance.
Marsh D, et al.
Biochemistry, 22(12), 3023-3026 (1983)
Suvasini Ramaswamy et al.
Proceedings of the National Academy of Sciences of the United States of America, 114(10), E1941-E1950 (2017-02-17)
Safe and efficient delivery of messenger RNAs for protein replacement therapies offers great promise but remains challenging. In this report, we demonstrate systemic, in vivo, nonviral mRNA delivery through lipid nanoparticles (LNPs) to treat a Factor IX (
Kaoru Nomura et al.
Biophysical journal, 117(1), 99-110 (2019-06-06)
After a nascent chain of a membrane protein emerges from the ribosomal tunnel, the protein is integrated into the cell membrane. This process is controlled by a series of proteinaceous molecular devices, such as signal recognition particles and Sec translocons.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service